DIAMOND LIGHT SOURCE LIMITED

What DIAMOND LIGHT SOURCE LIMITED does

Diamond Light Source Limited operates the UK's national synchrotron science facility, a third-generation 3 GeV medium-energy synchrotron located at the Harwell Science and Innovation Campus in Didcot, Oxfordshire. Founded in 2002 and operational since 2007, the facility generates X-ray light approximately 10 billion times brighter than the sun and directs it into 44 specialized beamline laboratories across eight science groups: macromolecular crystallography, imaging and microscopy, spectroscopy, soft condensed matter, magnetic materials, crystallography, structures and surfaces, and biological cryo-imaging. The organization also operates integrated specialized facilities including eBIC (five Titan Krios cryo-electron microscopes), ePSIC (probe-corrected JEM ARM200F and JEM ARM300F in partnership with University of Oxford and Johnson Matthey), XChem fragment screening, and the Membrane Protein Laboratory. Approximately 600–800 staff are employed at the Didcot site.

The entity is structured as a not-for-profit joint venture funded by UK Research & Innovation (UKRI, via the Science and Technology Facilities Council) and the Wellcome Trust. Academic and global researchers access beamtime through a peer-reviewed proposal system reviewed twice yearly (with BAG, Rapid, Long-Term and Proprietary Access routes), while industrial users access services through a dedicated Industrial Liaison Office offering tiered offerings — sample preparation, data collection, and full contract research — at quote-based pricing. The facility supports more than 8,000 scientists and researchers annually, including named industry users such as AstraZeneca, GSK, Merck, Vertex, Rolls-Royce, Unilever, Syngenta, Boston Scientific, Lubrizol, Johnson Matthey, Isomorphic Labs, and Insilico Medicine. An Industrial Science Committee (DISCo), chaired by Vertex, advises on industry engagement.

Diamond is currently executing the Diamond-II upgrade programme to a fourth-generation synchrotron, with the Diamond Extension Building opened in March 2026 and a new Coherent Soft X-ray Imaging and Diffraction (CSXID) beamline I17 planned. Recent strategic moves include the 2025 Cancer Research Horizons drug discovery partnership, the May 2026 UK-France Strategic Biomedical Alliance in Health and AI with University of Oxford, Synchrotron Soleil, Université Paris Cité and Institut Pasteur, and the June 2026 Vesuvius Challenge breakthrough enabling virtual unwrapping of the Herculaneum scrolls. Diamond is governed by a Board of Directors under new interim chair Professor Michael Fitzpatrick (from June 2026) and operates a recently appointed Director of Operations (Francesca Gliubich, May 2026).

Name

DIAMOND LIGHT SOURCE LIMITED

Legal name

Diamond Light Source Ltd

Website

https://diamond.ac.uk

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Diamond Light Source operates the UK's national synchrotron science facility at Harwell Campus, providing 44 specialized beamlines and integrated cryo-EM and electron-microscopy capabilities to academic and industry researchers worldwide via UKRI and Wellcome funding.

Ownership category

akta.pro rank

Headquarters

HQ city

Didcot

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain

Revenue model

1. Government and Charitable Funding: Diamond Light Source is a not-for-profit joint venture funded by UK Research & Innovation (UKRI) and Wellcome. Core operations and capital investments are supported through this funding model rather than commercial revenue generation.
2. Beamtime Access (Academic): Academic researchers submit peer-reviewed proposals for beamtime access. Financial support and expenses procedures exist for eligible users, with the facility covering shipping costs for samples.
3. Industry Services and Contract Research: Industry users pay for services including sample preparation and screening, data collection, and full contract research. Flexible access modes accommodate different industry requirements and timelines.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Diamond Light Source operates the UK's national synchrotron facility, generating extremely bright X-ray light (10 billion times brighter than the sun) directed into over 40 specialized beamlines for atomic and molecular-level scientific research. The facility serves both academic researchers through a peer-reviewed proposal system and industry clients through dedicated liaison services offering sample preparation, data collection, and full contract research. Integrated facilities include eBIC cryo-electron microscopy, ePSIC electron microscopy, XChem fragment screening, and the Membrane Protein Laboratory, with the Diamond-II upgrade underway to deliver fourth-generation capabilities.

Product overview

Diamond Light Source is the UK's national synchrotron science facility operating as a single, unified research infrastructure. The core offering is a synchrotron light source producing extremely bright X-ray light directed into over 40 specialized beamlines for scientific research. These beamlines are organized into eight science groups (Macromolecular Crystallography, Soft Condensed Matter, Imaging and Microscopy, Biological Cryo-Imaging, Magnetic Materials, Structures and Surfaces, Crystallography, and Spectroscopy) and include integrated facilities such as eBIC (cryo-electron microscopy), ePSIC (electron microscopy for physical sciences), XChem (fragment screening), and the Membrane Protein Laboratory. The Diamond-II upgrade is underway to create a fourth-generation synchrotron with enhanced capabilities. Services are provided to academic researchers through peer-reviewed access and to industry clients through dedicated liaison teams and flexible access modes.

Differentiator

Problem solved

Functional benefit

Products and services

• Synchrotron Light Source Access
• Industry Services - Sample Preparation and Screening
• Industry Services - Data Collection
• Industry Services - Contract Research
• eBIC - Cryo-Electron Microscopy Facility
• ePSIC - Electron Microscopy for Physical Sciences

Quantifiable outcome

• Foot-and-mouth disease vaccine candidate projected to deliver $1.3 billion annual economic benefits and $11 billion in avoided losses over ten years at 20% market penetration
• +3 more outcomes

Named customers19 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Vesuvius ChallengecoreStrategic or Co-development Partner · 25 June 2026Historic breakthrough in virtually unwrapping ancient Herculaneum scrolls buried by Mount Vesuvius. Diamond provided high-resolution micro-CT scanning enabling decoding of 1.5 meters of text from scroll PHerc. 1667 and recovery of 70+ columns from PHerc. 172.
• University of OxfordcoreStrategic or Co-development Partner · 29 May 2026UK-France Strategic Biomedical Alliance in Health and AI partnership announced at G7 Digital and Technology Ministerial Summit in Paris. Involves advanced imaging and AI for women's health research focusing on childbirth complications and endometriosis. Supported by £900m UK funding for computing infrastructure.
• Synchrotron SoleilcoreStrategic or Co-development Partner · 29 May 2026UK-France Strategic Biomedical Alliance partner providing synchrotron infrastructure alongside Diamond Light Source for collaborative biomedical and AI health research.
• Université Paris CitécoreStrategic or Co-development Partner · 29 May 2026French university partner in UK-France biomedical and AI health alliance, contributing research expertise in women's health and medical imaging.
• Institut PasteurcoreStrategic or Co-development Partner · 29 May 2026Prestigious French research institution partner in UK-France biomedical alliance, bringing expertise in infectious diseases and medical research.
• Cancer Research HorizonscoreStrategic or Co-development Partner · 29 May 2025Drug discovery partnership established in 2025 to accelerate cancer research through structural biology and fragment screening capabilities at Diamond.
• DISCo (Diamond Industrial Science Committee)coreStrategic or Co-development PartnerDiamond Industrial Science Committee advising CEO and Directors on industrial engagement opportunities. Members include Vertex (Chair), Rolls-Royce, AstraZeneca, GSK, Johnson Matthey, Infineum, NNL, Isomorphic Labs, NPL, Syngenta, RSSL, Astex Pharmaceuticals.
• Instruct-ERICcoreStrategic or Co-development PartnerEuropean research infrastructure for structural biology. Diamond is an active member with specific guidance on publication acknowledgements for EU structural biology community users.
• University of OxfordcoreStrategic or Co-development PartnerePSIC electron microscopy partnership with University of Oxford for JEM ARM300F microscope. Collaboration enables advanced physical sciences electron microscopy capabilities.
• Johnson MattheycoreStrategic or Co-development PartnerePSIC partnership with Johnson Matthey for JEM ARM200F probe-corrected microscope with EELS and EDX capabilities. Collaborative research in catalysis and materials characterization.
• Biblioteca Nazionale di NapoliminorOthersNational library in Naples housing the Herculaneum scrolls that were scanned at Diamond for the Vesuvius Challenge breakthrough.
• Oxford's Bodleian LibraryminorOthersScrolls also housed at Oxford's Bodleian Library as part of the Vesuvius Challenge research collaboration.
• Rosalind Franklin InstitutecoreStrategic or Co-development PartnerFormal agreement recognizing longstanding partnership between Diamond and the Rosalind Franklin Institute for joint commitment to scientific partnership.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• DESY (Deutsches Elektronen-Synchrotron): German national accelerator laboratory operating PETRA III (and the upcoming PETRA-IV fourth-generation upgrade), with parallel photon-science, structural biology, and materials-science user programmes. Directly comparable as a European national user facility undergoing similar upgrade pressures.
• MAX IV Laboratory: Sweden's national synchrotron, the first operational fourth-generation diffraction-limited storage-ring synchrotron. Comparable beamline mix and Nordic/European user base; represents the leading-edge peer whose user experience Diamond-II is intended to match or exceed.
• Canadian Light Source: Canada's national synchrotron at the University of Saskatchewan, offering comparable beamline services to academic and industrial users. Smaller in scale than Diamond but with directly overlapping user base in life sciences and materials.
• Paul Scherrer Institute (Swiss Light Source / SLS 2.0): Swiss national synchrotron facility currently upgrading SLS to SLS 2.0, a fourth-generation source. Comparable mid-energy class, similar industry access programmes, and similar timing of upgrade delivery to Diamond-II.
• Advanced Photon Source (Argonne National Laboratory): U.S. Department of Energy synchrotron at Argonne, currently undergoing the APS-U upgrade to a fourth-generation multi-bend achromat lattice. Comparable in beamline count, user scale, and industrial engagement model to Diamond.
• Synchrotron Soleil: France's national synchrotron, comparable in scale and energy class to Diamond, serving European academic and industry users across similar beamline disciplines. Soleil is a UK-France alliance partner under the 2026 G7-announced biomedical alliance.
• European Synchrotron Radiation Facility (ESRF): The ESRF in Grenoble operates a high-energy synchrotron and is the closest functional peer to Diamond, with overlapping user communities in structural biology, materials science, and heritage science. Diamond and ESRF already co-execute projects such as Vesuvius Challenge micro-CT scans.
• Brookhaven National Laboratory (NSLS-II): U.S. DOE synchrotron (National Synchrotron Light Source II), a third-generation facility comparable in energy class and beamline diversity to Diamond, with similar national-laboratory governance and industry engagement.
• SPring-8 / JASRI: Japan's flagship 8 GeV synchrotron, operated by JASRI, with industry access and a large beamline suite. Comparable in scale and breadth; SPring-8-II upgrade plans represent similar competitive dynamics to Diamond-II.
• SLAC National Accelerator Laboratory: U.S. national accelerator complex operating SSRL (Stanford Synchrotron Radiation Lightsource) and Linac Coherent Light Source (XFEL). Comparable structural-biology and materials-science user programmes with industry access, particularly relevant given Diamond's UK XFEL Hub affiliation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/DiamondLightSou
• Facebookfacebook.com/DiamondLightSource
• LinkedInlinkedin.com/company/diamond-light-source
• Instagraminstagram.com/diamondlightsource

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DIAMOND LIGHT SOURCE LIMITED